Imaging Study of Chronic Low Back Pain in Patients Taking Pain Medication
CompletedNot applicableNCT00388414
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Duloxetine has recently been shown to be effective in reducing the pain in chronic pain patients. Duloxetine is known to exert a central mechanism, however the precise human brain structures responsible for mediating its pain-relieving properties are not known. We will use functional magnetic resonance imaging (FMRI) to investigate the neural and functional correlates of pain.
Study details
- Official title
- Functional MRI Neural Correlates of Medication Efficacy in Patients With Chronic Low Back Pain
- Conditions
- Interventions
- Sponsor
- Stanford University
- Start date
- 2006-09
- Primary completion
- 2010-01
- Sex
- Male
- Age range
- from 18 Years to 60 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria:- Males aged 18-60 * Back Pain * Must be able to comply with study visit schedule and other study requirements * Capable of performing the experimental tasks Exclusion Criteria:- Contraindications for MRI examination (e.g., metallic implants such as pacemakers, surgical aneurysm clips, or known metal fragments embedded in the body) * Known hypersensitivity to duloxetine or any of the inactive ingredients * Uncontrolled narrow-angle glaucoma
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00388414